These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 36168693)
41. A double blind placebo controlled trial of ginkgo biloba extract in acute cerebral ischaemia. Garg RK; Nag D; Agrawal A J Assoc Physicians India; 1995 Nov; 43(11):760-3. PubMed ID: 8773035 [TBL] [Abstract][Full Text] [Related]
42. Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study. Mazza M; Capuano A; Bria P; Mazza S Eur J Neurol; 2006 Sep; 13(9):981-5. PubMed ID: 16930364 [TBL] [Abstract][Full Text] [Related]
43. Identification of proteins differentially expressed in cerebral cortexes of Ginkgo biloba extract (EGb761)-treated rats in a middle cerebral artery occlusion model--a proteomics approach. Koh PO Am J Chin Med; 2011; 39(2):315-24. PubMed ID: 21476208 [TBL] [Abstract][Full Text] [Related]
44. Experimental evidence of Ginkgo biloba extract EGB as a neuroprotective agent in ischemia stroke rats. Zhang Z; Peng D; Zhu H; Wang X Brain Res Bull; 2012 Feb; 87(2-3):193-8. PubMed ID: 22100334 [TBL] [Abstract][Full Text] [Related]
46. Preliminary EEG study of protective effects of Tebonin in transient global cerebral ischemia in rats. Zăgrean L; Vătăşescu R; Munteanu AM; Moldovan M; Niţă DA; Coculescu M Rom J Physiol; 1998; 35(1-2):161-8. PubMed ID: 11000876 [TBL] [Abstract][Full Text] [Related]
47. Polysomnographic effects of adjuvant ginkgo biloba therapy in patients with major depression medicated with trimipramine. Hemmeter U; Annen B; Bischof R; Brüderlin U; Hatzinger M; Rose U; Holsboer-Trachsler E Pharmacopsychiatry; 2001 Mar; 34(2):50-9. PubMed ID: 11302564 [TBL] [Abstract][Full Text] [Related]
48. [Results of combined treatment for vestibular receptor impairment with physical therapy and Ginkgo biloba extract (Egb 761)]. Orendorz-Fraczkowska K; Pośpiech L; Gawron W Otolaryngol Pol; 2002; 56(1):83-8. PubMed ID: 12053674 [TBL] [Abstract][Full Text] [Related]
49. [Neuroprotectors in the correction of cognitive impairment]. Shavlovskaya OA Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(9):130-132. PubMed ID: 30335085 [TBL] [Abstract][Full Text] [Related]
50. Effect of one week treatment with Ginkgo biloba extract (EGb761) on ischemia-induced infarct volume in gerbils. Chung SY; Wang MF; Lin JY; Lin MC; Liu HM; Cheng FC Am J Chin Med; 2003; 31(4):533-42. PubMed ID: 14587876 [TBL] [Abstract][Full Text] [Related]
51. [The situation of patients with dementia may be rectified by Ginkgo biloba. Results of a health services research study concerning the ability of patients with dementia, quality of life of the nursing family members and total treatment costs]. Heinen-Kammerer T; Motzkat K; Daniel D; Gertz HJ; Koller M; Lorenz W; Pilartz H; Zimmer B; Habs M; von den Driesch V; Rychlik R MMW Fortschr Med; 2005 Oct; 147 Suppl 3():127-33. PubMed ID: 16261949 [TBL] [Abstract][Full Text] [Related]
52. Benefits of Treatment with Ginkgo Biloba Extract EGb 761 Alone or Combined with Acetylcholinesterase Inhibitors in Vascular Dementia. García-Alberca JM; Mendoza S; Gris E Clin Drug Investig; 2022 May; 42(5):391-402. PubMed ID: 35349093 [TBL] [Abstract][Full Text] [Related]
53. Ticlopidine with Ginkgo Biloba extract: a feasible combination for patients with acute cerebral ischemia. Hong JM; Shin DH; Lim YA; Lee JS; Joo IS Thromb Res; 2013 Apr; 131(4):e147-53. PubMed ID: 23477707 [TBL] [Abstract][Full Text] [Related]
54. The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF). Smith PF; Maclennan K; Darlington CL J Ethnopharmacol; 1996 Mar; 50(3):131-9. PubMed ID: 8691847 [TBL] [Abstract][Full Text] [Related]
55. [The evaluation by video capillaroscopy of the efficacy of a Ginkgo biloba extract with L-arginine and magnesium in the treatment of trophic lesions in patients with stage-IV chronic obliterating arteriopathy]. Pepe C; Rozza A; Veronesi G Minerva Cardioangiol; 1999 Jun; 47(6):223-30. PubMed ID: 10522149 [TBL] [Abstract][Full Text] [Related]
56. The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia. DeKosky ST; Fitzpatrick A; Ives DG; Saxton J; Williamson J; Lopez OL; Burke G; Fried L; Kuller LH; Robbins J; Tracy R; Woolard N; Dunn L; Kronmal R; Nahin R; Furberg C; Contemp Clin Trials; 2006 Jun; 27(3):238-53. PubMed ID: 16627007 [TBL] [Abstract][Full Text] [Related]
57. Toxicology and carcinogenesis studies of Ginkgo biloba extract (CAS No. 90045-36-6) in F344/N rats and B6C3F1/N mice (Gavage studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2013 Mar; (578):1-183. PubMed ID: 23652021 [TBL] [Abstract][Full Text] [Related]
59. Influence of the severity of cognitive impairment on the effect of the Gnkgo biloba extract EGb 761 in Alzheimer's disease. Le Bars PL; Velasco FM; Ferguson JM; Dessain EC; Kieser M; Hoerr R Neuropsychobiology; 2002; 45(1):19-26. PubMed ID: 11803237 [TBL] [Abstract][Full Text] [Related]
60. Effects of oxiracetam combined with ginkgo biloba extract in the treatment of acute intracerebral hemorrhage: A clinical study. Li XX; Liu SH; Zhuang SJ; Guo SF; Pang SL Brain Behav; 2020 Aug; 10(8):e01661. PubMed ID: 32533644 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]